This editorial has been replaced with a link to information about Team Sarcoma 2006 at the Team Sarcoma website.
Lobbying for the "Exceptionally Rare Diseases and Conditions Act"
Dr. Mark Thornton discusses a bill, that if brought before Congress and passed, would provide a unique pathway for new drugs for sarcoma patients.
Julia D. Royster, Ph.D. tells us there is a growing body of evidence that specific mutation status can contribute prognostic information in GIST.
Rachel Baumgartner shares with us some poems she wrote en route to becoming a survivor of Askin's tumor.
Kelly Wilson tells why her daughter Tylar's dog Andy is a person, not a dog!